Eisenberger, U; Huynh-Do, U (2006). [Microalbuminuria--a new cardiovascular risk factor?]. Therapeutische Umschau, 63(9), pp. 565-8. Bern: Huber 10.1024/0040-5930.62.9.597
Full text not available from this repository. (Request a copy)Microalbuminuria is an established risk factor for renal disease, especially in the diabetic population. Recent studies have shown that microalbuminuria has also a highly relevant predictive value for cardiovascular morbidity and mortality. From normal to overt proteinuria levels, albuminuria shows a continuous marked increase in cardiovascular risk. This association is independent of other "classical" cardiovascular risk factors such as hypertension, hyperlipidemia or smoking. Furthermore it has a predictive value not only for patients with diabetic or renal disease, but also for hypertensive individuals or the general population. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have been shown to display not only reno--but also cardioprotective effects. Their unique ability to lower albuminuria by 40% is related to a significant risk reduction in cardiovascular mortality. New clinical trials are needed to define "normal" albuminuria levels and how low we should go.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension |
UniBE Contributor: |
Eisenberger, Ute, Huynh-Do, Uyen |
ISSN: |
0040-5930 |
ISBN: |
17048169 |
Publisher: |
Huber |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:47 |
Last Modified: |
05 Dec 2022 14:14 |
Publisher DOI: |
10.1024/0040-5930.62.9.597 |
PubMed ID: |
17048169 |
Web of Science ID: |
000232107500004 |
URI: |
https://boris.unibe.ch/id/eprint/19774 (FactScience: 2717) |
Actions (login required)
 |
Edit item |